This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wise-Draper, T. M. Articles by Wells, S. I. Search for Related Content PubMed PubMed Citation Articles by Wise-Draper, T. M. Articles by Wells, S. I.

The Human DEK Proto-Oncogene Is a Senescence Inhibitor and an Upregulated Target of High-Risk Human Papillomavirus E7

Division of Hematology/Oncology, Children's Hospital Medical Center and The University of Cincinnati College of Medicine, Cincinnati, Ohio 45229,¹ Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267,² The Channing Laboratory, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts³

Received 2 June 2005/ Accepted 19 August 2005

The human DEK proto-oncogene is a nucleic acid binding protein with suspected roles in human carcinogenesis, autoimmune disease, and viral infection. Intracellular DEK functions, however, are poorly understood. In papillomavirus-positive cervical cancer cells, downregulation of viral E6/E7 oncogene expression results in cellular senescence. We report here the specific repression of DEK message and protein levels in senescing human papillomavirus type 16- (HPV16-) and HPV18-positive cancer cell lines as well as in primary cells undergoing replicative senescence. Cervical cancer cell senescence was partially overcome by DEK overexpression, and DEK overexpression was sufficient for extending the life span of primary keratinocytes, supporting critical roles for this molecule as a senescence regulator. In order to determine whether DEK is a bona fide HPV oncogene target in primary cells, DEK expression was monitored in human keratinocytes transduced with HPV E6 and/or E7. The results identify high-risk HPV E7 as a positive DEK regulator, an activity that is not shared by low-risk HPV E7 protein. Experiments in mouse embryo fibroblasts recapitulated the observed E7-mediated DEK induction and demonstrated that both basal and E7-induced regulation of DEK expression are controlled by the retinoblastoma protein family. Taken together, our results suggest that DEK upregulation may be a common event in human carcinogenesis and may reflect its senescence inhibitory function.

This article has been cited by other articles:

• Kappes, F., Fahrer, J., Khodadoust, M. S., Tabbert, A., Strasser, C., Mor-Vaknin, N., Moreno-Villanueva, M., Burkle, A., Markovitz, D. M., Ferrando-May, E. (2008). DEK Is a Poly(ADP-Ribose) Acceptor in Apoptosis and Mediates Resistance to Genotoxic Stress. Mol. Cell. Biol. 28: 3245-3257 [Abstract] [Full Text]  
• Devany, M., Kappes, F., Chen, K.-M., Markovitz, D. M., Matsuo, H. (2008). Solution NMR structure of the N-terminal domain of the human DEK protein. Protein Sci. 17: 205-215 [Abstract] [Full Text]  
• Abba, M. C., Sun, H., Hawkins, K. A., Drake, J. A., Hu, Y., Nunez, M. I., Gaddis, S., Shi, T., Horvath, S., Sahin, A., Aldaz, C. M. (2007). Breast Cancer Molecular Signatures as Determined by SAGE: Correlation with Lymph Node Status. Mol Cancer Res 5: 881-890 [Abstract] [Full Text]  
• Johung, K., Goodwin, E. C., DiMaio, D. (2007). Human Papillomavirus E7 Repression in Cervical Carcinoma Cells Initiates a Transcriptional Cascade Driven by the Retinoblastoma Family, Resulting in Senescence. J. Virol. 81: 2102-2116 [Abstract] [Full Text]  
• Wise-Draper, T. M., Allen, H. V., Jones, E. E., Habash, K. B., Matsuo, H., Wells, S. I. (2006). Apoptosis Inhibition by the Human DEK Oncoprotein Involves Interference with p53 Functions. Mol. Cell. Biol. 26: 7506-7519 [Abstract] [Full Text]